iTonic Holdings Ltd.
ITOC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$19.14M
Close$
$0.22
92.5% downside
Current Fair Value
92.5% downsideOvervalued by 92.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $19.14 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-5.12 |
| Beta | 2.79 |
| Outstanding Shares | 4,484,133 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.67 |
|---|---|
| PEG | -0.36 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.65%▲ 1.08% |
|---|---|
| Total Invested | $84,048▲ 146.35% |
| Investors Holding | 12▲ 4.00% |
About iTonic Holdings Ltd.
7 employees
CEO: Jianfei Zhang
iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implant...